China Grand Pharmaceutical and Healthcare Holdings Ltd (512)-医療機器分野:企業M&A・提携分析

◆英語タイトル:China Grand Pharmaceutical and Healthcare Holdings Ltd (512) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011503
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company’s product categories include preparations, APIs, steroid hormones APIs, healthcare products and agricultural and fine chemicals. China Grand’s preparation products comprise cardiovascular, ophthalmic gel and eye drops, antibacterial, antibiotics, and antipyretics and analgesic. The company provides raw materials such as amino acids, sterold hormones, and others. It distributes its products through a network of distributors in domestic and overseas markets. The company operates in Beijing, Hubei, Zhejiang and Hong Kong. China Grand is headquartered in Hong Kong.

China Grand Pharmaceutical and Healthcare Holdings Ltd (512) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Conavi Medical Enters into Distribution Agreement with China Grand Pharma 10
Grand Pharma Forms Joint Venture With Huangshi Feiyun Pharma 11
Equity Offering 12
Conavi Medical to Raise USD7.5 Million in Private Placement of Shares 12
China Grand Pharma and Healthcare to Raise USD13.7 Million in Private Placement of Shares 13
China Grand Pharma Raises USD22 Million in Private Placement of Shares 14
China Grand Pharmaceutical and Healthcare Holdings Ltd – Key Competitors 16
China Grand Pharmaceutical and Healthcare Holdings Ltd – Key Employees 17
China Grand Pharmaceutical and Healthcare Holdings Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Nov 14, 2016: China Grand Pharmaceutical and Healthcare Holdings: Change Of Directors 19
Other Significant Developments 20
Feb 24, 2017: China Grand Pharmaceutical and Healthcare Holdings: Voluntary Announcement In Related To The Products Newly Included In The 2017 National Medical Reimbursement List 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment, Key Facts, 2016 2
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
China Grand Pharmaceutical and Healthcare Holdings Ltd, Deals By Market, 2011 to YTD 2017 8
China Grand Pharmaceutical and Healthcare Holdings Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Conavi Medical Enters into Distribution Agreement with China Grand Pharma 10
Grand Pharma Forms Joint Venture With Huangshi Feiyun Pharma 11
Conavi Medical to Raise USD7.5 Million in Private Placement of Shares 12
China Grand Pharma and Healthcare to Raise USD13.7 Million in Private Placement of Shares 13
China Grand Pharma Raises USD22 Million in Private Placement of Shares 14
China Grand Pharmaceutical and Healthcare Holdings Ltd, Key Competitors 16
China Grand Pharmaceutical and Healthcare Holdings Ltd, Key Employees 17
China Grand Pharmaceutical and Healthcare Holdings Ltd, Subsidiaries 18

★海外企業調査レポート[China Grand Pharmaceutical and Healthcare Holdings Ltd (512)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Advicenne SA (ADVIC):製薬・医療:M&Aディール及び事業提携情報
    Summary Advicenne SA (Advicenne) is a developer of pediatric medicines. The company offers product portfolio such as ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of micro-tablets for renal tubulopathies. It p …
  • Just Group plc:戦略・SWOT・企業財務分析
    Just Group plc - Strategy, SWOT and Corporate Finance Report Summary Just Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Linde Malaysia Sdn Bhd:企業の戦略的SWOT分析
    Linde Malaysia Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Universal Health Services Inc (UHS):企業の財務・戦略的SWOT分析
    Universal Health Services Inc (UHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Excelsior Capital Ltd (ECL):企業の財務・戦略的SWOT分析
    Excelsior Capital Ltd (ECL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Liberty House Group:企業の戦略・SWOT・財務情報
    Liberty House Group - Strategy, SWOT and Corporate Finance Report Summary Liberty House Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vetoquinol SA (VETO):企業の財務・戦略的SWOT分析
    Summary Vetoquinol SA (Vetoquinol) is a veterinary pharmaceutical company that develops, produces and distributes veterinary drugs and non-medicinal products. The company provides pain management, anti-infective, hygiene and care, pest control, behavior, internal medicine, reproduction, behaviour an …
  • Providence Resources plc (PZQA):企業の財務・戦略的SWOT分析
    Summary Providence Resources Plc (Providence Resource) is an upstream oil and gas exploration and development company that explores and develops hydrocarbon assets. The company's areas of operations include Northern Porcupine basin, Southern Porcupine basin, Goban Spur basin, Saint George's basin an …
  • Engie SA (ENGI):電力:M&Aディール及び事業提携情報
    Summary Engie SA (Engie) is an electric utility. It provides electricity, natural gas, and energy services. It generates electricity from hydro, wind, biomass, and solar sources, and trades and sells that energy; supplies, distributes, trades, and sells natural gas; and offers a comprehensive range …
  • SIFCO Industries, Inc.:戦略・SWOT・企業財務分析
    SIFCO Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary SIFCO Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ophthotech Corp (OPHT):企業の財務・戦略的SWOT分析
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt disease. It also provides Fovista, a …
  • Parexel International Corp:企業の戦略的SWOT分析
    Parexel International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Snyder’s-Lance, Inc.:戦略・SWOT・企業財務分析
    Snyder's-Lance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Snyder's-Lance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Avillion LLP-製薬・医療分野:企業M&A・提携分析
    Summary Avillion LLP (Avillion) is a provider of drug development services. The company supports pharmaceutical and biotechnology companies to develop drug candidates without increasing the burden on them. It maintains a business model for the clinical development and regulatory approval of late sta …
  • Dometic Group AB:企業の戦略・SWOT・財務情報
    Dometic Group AB - Strategy, SWOT and Corporate Finance Report Summary Dometic Group AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務情報
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sucrerie Couplet SA:企業の戦略・SWOT・財務情報
    Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report Summary Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Eurobio Scientific SA (ALEHT):医療機器:M&Aディール及び事業提携情報
    Summary Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, which is used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic i …
  • Blue Apron Holdings Inc (APRN):企業の財務・戦略的SWOT分析
    Blue Apron Holdings Inc (APRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Toshiba America Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Toshiba America Medical Systems Inc (TAMS), a subsidiary of Toshiba Medical Systems Corp, is a medical device company which markets and distributes the diagnostic imaging systems. The company offers cardiovascular X-ray, computed tomography, angiography, magnetic resonance, ultrasound and x- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆